Skip to main content
Fig. 2 | BMC Pulmonary Medicine

Fig. 2

From: Outcome of corticosteroid administration in autoimmune pulmonary alveolar proteinosis: a retrospective cohort study

Fig. 2

A typical clinical course of a case of autoimmune pulmonary alveolar proteinosis treated with corticosteroid administration. The upper column indicates schematic dose of the administered prednisolone (PSL) and antifungal agents each day. The middle column indicates the time course of chest HRCT appearance (Days after the first visit were shown by arrays). The lower column indicates serum levels of Krebs von den Lungen-6 (KL-6), surfactant protein D (SP-D), β-D glucan, Aspergillus antigen (Asper. ag.) and granulocyte/macrophage colony-stimulating factor autoantibody (GMAb). MCFG: Micafungin; VRCZ: Voriconazole; AMPH: amphotericin B; ITCZ: Itraconazole

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us